Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Electron Transport Chain Deficiencies, Mitochondrial

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alves, E1
Binienda, Z1
Carvalho, F1
Alves, CJ1
Fernandes, E1
de Lourdes Bastos, M1
Tavares, MA1
Summavielle, T1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.
    Neuroscience, 2009, Jan-23, Volume: 158, Issue:2

    Topics: Acetylcarnitine; Animals; Body Weight; Brain; Cyclooxygenase 1; DNA, Mitochondrial; Fever; Hallucino

2009